Cytek Biosciences Investor Relations Material
Latest events
Q4 2023
Cytek Biosciences
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Cytek Biosciences Inc
Access all reports
Cytek Biosciences, Inc. is a developer of cell analysis tools that facilitate scientific advances in biomedical research and clinical applications. The company develops and sells products that automate data acquisition from cells using its proprietary Cassette-based Cell Culture Platform. Cytek Biosciences, Inc. serves customers worldwide, among other, many prominent institutions around the world including NASA, Cedars-Sinai Medical Center, Walter Reed National Military Medical Center, University of Nebraska Engineering Department, Johns Hopkins School of Medicine, Albert Einstein College of Medicine.
Key slides for Cytek Biosciences Inc
J.P. Morgan 42nd Annual Healthcare Conference 2024
Cytek Biosciences Inc
J.P. Morgan 42nd Annual Healthcare Conference 2024
Cytek Biosciences Inc
Latest articles
Companies That Had Their IPO in 2023: Cautious Optimism
The cautiously optimistic market in 2023 saw stocks rebounded upwards, and interest in IPOs picked up from the previous year.
15 Apr 2024
Puig's 2024 IPO: Paco Rabanne, Jean Paul Gaultier, and Beyond
Explore Puig's journey from its 1914 inception to a 2024 IPO, showcasing its growth, strategic acquisitions, and impact in the beauty and fashion industry.
15 Apr 2024
Alphabet's Unstoppable Rise: From Stanford to Global Tech Leader
Discover Alphabet's rise from a university project to a global tech leader, highlighting its growth, diversification, and visionary leadership.
15 Apr 2024
Ticker symbol
Country
🇺🇸 United States